Business Daily Media

Men's Weekly

.

FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer

  • Written by PR Newswire

IND approved to trial PXS-5505 added to current standard of care in newly diagnosed unresectable hepatocellular carcinoma patients

University of Rochester Medical Center and Pharmaxis in discussions to commence investigator-led study in 2022

SYDNEY, Nov. 9, 2021 /PRNewswire/ -- Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today...

From Check-in to Touchdown: How AI and smarter systems are transforming the travel industry

Richard Valente, VP of Customer Experience Strategy at TP in Australia, explores how IT-BPM outsourcing is revolutionising the travel sector throu...

Online Christmas shoppers fund climate and biodiversity projects via HealthPost's Click Sphere for Good initiative

Online shoppers with HealthPost’s Flora & Fauna have made 11,000 contributions towards climate and biodiversity projects when ordering parcel ...

US landmark settlement protects SMEs, highlighting flaws in the RBA's proposed blanket card surcharging ban for Australia

Aussie SMEs warn RBA not to ignore global trends, with the current sledgehammer approach threatening business viability and increasing inflation ...

Thryv Australia named Employer of Choice for third consecutive year at Australian Business Awards

Thryv® (NASDAQ: THRY), Australia’s provider of the leading small business marketing and sales software platform, has been awarded the Employer of ...

RogersDigital.com Announces the Launch of TheBulletin.au, a Destination for Business, Policy and Financial Insight

RogersDigital.com has announced the launch of TheBulletin.au, a new national digital publication designed to deliver sharp, data-driven reporting ...

Controlling business spend is helping finance leaders to forecast with confidence

Forecasting has always been central to financial planning; however, traditional methods based on historical trends are no longer enough. Economic ...